Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check42 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check49 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check71 days agoChange DetectedThe website has updated the intervention details and contact information for Principal Investigator Alona Zer, MD, while also revising the version from v2.13.3 to v2.14.0.SummaryDifference3%
- Check100 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.